MA42685A - Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation - Google Patents
Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisationInfo
- Publication number
- MA42685A MA42685A MA042685A MA42685A MA42685A MA 42685 A MA42685 A MA 42685A MA 042685 A MA042685 A MA 042685A MA 42685 A MA42685 A MA 42685A MA 42685 A MA42685 A MA 42685A
- Authority
- MA
- Morocco
- Prior art keywords
- hydrochloride
- dextromethadone
- synthesis
- methods
- levomethadone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562209168P | 2015-08-24 | 2015-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42685A true MA42685A (fr) | 2018-07-04 |
Family
ID=56853854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042685A MA42685A (fr) | 2015-08-24 | 2016-08-24 | Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation |
Country Status (5)
Country | Link |
---|---|
US (2) | US10040752B2 (fr) |
EP (1) | EP3341354A1 (fr) |
CN (1) | CN108137483A (fr) |
MA (1) | MA42685A (fr) |
WO (1) | WO2017035224A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10040752B2 (en) * | 2015-08-24 | 2018-08-07 | Cody Laboratories, Inc. | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof |
US20180214395A1 (en) * | 2017-01-31 | 2018-08-02 | Paolo L. Manfredi | Compounds for Treatment or Prevention of Disorders of the Nervous System and Symptoms and Manifestations Thereof, and for Cyto-Protection Against Diseases and Aging of Cells, and Symptoms and Manifestations Thereof |
CN108693272B (zh) * | 2018-06-04 | 2021-03-12 | 吉林百纯化学科技有限公司 | 一种hplc法分析及制备n-(对甲苯磺酰基)-l-丙氨酸及其对映异构体的方法 |
US20200033307A1 (en) * | 2018-07-25 | 2020-01-30 | Honeywell International Inc. | Method of determining an amount of water in a sample using a derivative of imidazole and a hydrogen halide donor |
US11332434B2 (en) * | 2019-04-17 | 2022-05-17 | Javad Safaei-Ghomi | Synthesis of levomethadone hydrochloride |
CN110818908B (zh) * | 2019-08-29 | 2021-12-17 | 杭州市富阳区浙工大银湖创新创业研究院 | 一种用于检测氧化气体的金属有机骨架材料的制备方法 |
JP2024514316A (ja) * | 2021-04-09 | 2024-04-01 | パオロ エル マンフレディ | エナンチオ純粋な(s)-メサドン、(r)-メサドン、ラセミ(r,s)-メサドン、及び関連類似体物質を合成するための新規方法 |
CA3224723A1 (fr) * | 2021-06-30 | 2023-01-05 | Paolo L. Manfredi | Formulations a liberation modifiee de methadone et ses isomeres, d'esmethadone et de levomethadone et derives |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2540636A (en) | 1947-11-12 | 1951-02-06 | Mallinckrodt Chemical Works | Separation of nitrile intermediates in amidone synthesis |
US2497739A (en) | 1949-01-05 | 1950-02-14 | Merck & Co Inc | Process of separating isomers of amidone intermediates |
US2601323A (en) | 1949-02-02 | 1952-06-24 | Upjohn Co | Process for preparing 4, 4-diphenyl-6-dimethylamino-heptanone-3 |
GB1124682A (en) | 1966-06-21 | 1968-08-21 | Wyeth John & Brother Ltd | Preparation of amines |
US4048211A (en) | 1976-05-10 | 1977-09-13 | Eli Lilly And Company | Modification of methadone synthesis process step |
US4242274A (en) | 1979-06-18 | 1980-12-30 | Mallinckrodt, Inc. | Process for the preparation of 2,2-diphenyl-4-(dimethylamino)-pentane nitrile |
GB9611041D0 (en) | 1996-05-25 | 1996-07-31 | Salford Ultrafine Chem & Res | Process for the preparation of optically active methadones in high enantiomeric purity |
SK287446B6 (sk) | 2007-02-08 | 2010-10-07 | Zentiva, A. S. | Spôsob prípravy metadóniumchloridu |
US10533000B2 (en) | 2011-05-26 | 2020-01-14 | Sunovion Pharmaceuticals, Inc. | Metabotrophic glutamate receptor 5 modulators and methods of use thereof |
MY183354A (en) | 2011-11-22 | 2021-02-18 | Univ Sains Malaysia | (r)-6-(dimthylamino)-4,4-diphenylheptan-3-one |
US9468611B2 (en) | 2012-09-27 | 2016-10-18 | Relmada Therapeutics, Inc. | d-Methadone for the treatment of psychiatric symptoms |
US10040752B2 (en) * | 2015-08-24 | 2018-08-07 | Cody Laboratories, Inc. | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof |
-
2016
- 2016-08-24 US US15/245,935 patent/US10040752B2/en active Active
- 2016-08-24 WO PCT/US2016/048380 patent/WO2017035224A1/fr active Application Filing
- 2016-08-24 MA MA042685A patent/MA42685A/fr unknown
- 2016-08-24 EP EP16760285.3A patent/EP3341354A1/fr not_active Withdrawn
- 2016-08-24 CN CN201680061096.XA patent/CN108137483A/zh active Pending
-
2018
- 2018-06-29 US US16/024,283 patent/US20190002394A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN108137483A (zh) | 2018-06-08 |
US20170057909A1 (en) | 2017-03-02 |
WO2017035224A1 (fr) | 2017-03-02 |
US10040752B2 (en) | 2018-08-07 |
EP3341354A1 (fr) | 2018-07-04 |
US20190002394A1 (en) | 2019-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
MA44955A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
MA45123A (fr) | Anticorps anti-tim-3 et leurs méthodes d'utilisation | |
MA50957A (fr) | Anticorps anti-tigit et leurs méthodes d'utilisation | |
MA43387A (fr) | Anticorps anti-gitr et leurs méthodes d'utilisation | |
MA42925A (fr) | Anticorps anti-tigit et méthodes d'utilisation | |
MA42302A (fr) | Lactames bicycliques et leurs méthodes d'utilisation | |
MA49288A (fr) | Reactifs particulaires oligomères et leurs méthodes d'utilisation | |
MA48595A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
MA42685A (fr) | Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation | |
ZA201704985B (en) | Oral care compositions and methods of use | |
MA43284A (fr) | Composés et leurs méthodes d'utilisation | |
MA55097A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA42243A (fr) | Anticorps de facteur xi et méthodes d'utilisation | |
MA46566A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA42409A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA46565A (fr) | Oxystérols et leurs procédés d'utilisation | |
MA49715A (fr) | Oligomères et conjugués d'oligomères | |
MA44526A (fr) | Oxystérols et leurs méthodes d'utilisation | |
MA54851A (fr) | Oxystérols et leurs procédés d'utilisation | |
FR3022147B1 (fr) | Module robotise d'entrainement d'organe medical souple allonge | |
MA44081A (fr) | Anticorps anti-c5 et leurs procédés d'utilisation | |
FR3044541B1 (fr) | Module robotise d'entrainement d'organe medical souple allonge | |
MA43385A (fr) | Nouveaux anticorps anti-claudine et méthodes d'utilisation | |
MA42118A (fr) | Benzamides substitués et leurs méthodes d'utilisation |